We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.78B
AUM Growth
+$56.1M
Cap. Flow
-$188M
Cap. Flow %
-3.26%
Top 10 Hldgs %
16.17%
Holding
795
New
72
Increased
310
Reduced
286
Closed
45

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$28.5M
2
META icon
Meta Platforms (Facebook)
META
+$26M
3
TRV icon
Travelers Companies
TRV
+$17.1M
4
LUV icon
Southwest Airlines
LUV
+$16.6M
5
CI icon
Cigna
CI
+$16.6M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$76.5M
2
JNJ icon
Johnson & Johnson
JNJ
+$27.8M
3
GILD icon
Gilead Sciences
GILD
+$26.5M
4
CPB icon
Campbell Soup
CPB
+$20.6M
5
AMZN icon
Amazon
AMZN
+$20.2M

Sector Composition

Rank Sector Weight
1 Healthcare 22.62%
2 Technology 14.65%
3 Financials 14.55%
4 Consumer Discretionary 9.89%
5 Communication Services 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NCLH icon
626
Norwegian Cruise Line
NCLH
$8.89B
$630K 0.01%
11,822
-1,001
-8% -$55.4K
SHPG
627
DELISTED
Shire pic
SHPG
$629K 0.01%
4,055
-2,251
-36% -$334K
SNI
628
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
$624K 0.01%
7,306
-10,377
-59% -$858K
SHG icon
629
Shinhan Financial Group
SHG
$33.6B
$623K 0.01%
13,425
SNDX icon
630
Syndax Pharmaceuticals
SNDX
$1.84B
$613K 0.01%
+70,000
New +$693K
UTHR icon
631
United Therapeutics
UTHR
$26.3B
$613K 0.01%
4,142
+1,919
+86% +$244K
WCG
632
DELISTED
Wellcare Health Plans, Inc.
WCG
$603K 0.01%
3,000
NSTG
633
DELISTED
NanoString Technologies, Inc.
NSTG
$598K 0.01%
80,000
-26,000
-25% -$247K
KL
634
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
$594K 0.01%
+38,621
New +$532K
ATO icon
635
Atmos Energy
ATO
$29.9B
$593K 0.01%
6,900
+4
+0.1% +$352
DISCK
636
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$592K 0.01%
27,960
-20,081
-42% -$370K
DNKN
637
DELISTED
Dunkin' Brands Group, Inc.
DNKN
$580K 0.01%
9,000
AGI icon
638
Alamos Gold
AGI
$12.4B
$571K 0.01%
+87,691
New +$572K
EG icon
639
Everest Group
EG
$15.2B
$563K 0.01%
2,546
-6,142
-71% -$1.38M
XRX icon
640
Xerox
XRX
$337M
$561K 0.01%
19,229
+870
+5% +$26.4K
DPZ icon
641
Domino's
DPZ
$11B
$558K 0.01%
+2,952
New +$547K
LXFT
642
DELISTED
Luxoft Holding, Inc.
LXFT
$557K 0.01%
10,000
CSOD
643
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$551K 0.01%
15,600
IFN
644
Aberdeen India Fund
IFN
$488M
$549K 0.01%
+21,000
New +$579K
AYI icon
645
Acuity Brands
AYI
$9.88B
$545K 0.01%
3,098
-180
-5% -$29.9K
UNFI icon
646
United Natural Foods
UNFI
$3.01B
$542K 0.01%
11,000
VTVT icon
647
vTv Therapeutics
VTVT
$121M
$541K 0.01%
2,250
-1,250
-36% -$280K
THG icon
648
Hanover Insurance
THG
$7.63B
$540K 0.01%
5,000
AUPH icon
649
Aurinia Pharmaceuticals
AUPH
$1.97B
$535K 0.01%
118,000
SMG icon
650
ScottsMiracle-Gro
SMG
$4.03B
$535K 0.01%
+5,000
New +$499K

Similar funds

Candriam SCA's Q4 2017 Portfolio in Review

As of Q4 2017, Candriam SCA held 795 positions worth $5.78B, up 0.98% from $5.72B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA withdrew a net $188M in Q4 2017, closing 45 positions and reducing 286 holdings. Its most notable exit was Hubbell, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in 58.com Inc worth $15.6M.

  • Candriam SCA's largest Q4 2017 buy was 58.com Inc: 218,000 shares worth $15.6M.
  • Candriam SCA added most to Amgen in Q4 2017, an estimated $28.5M increase.
  • Candriam SCA's biggest Q4 2017 reduction was Biogen, cutting an estimated $76.5M.
  • Candriam SCA fully exited Hubbell in Q4 2017, selling an estimated $11.1M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.78B portfolio in Q4 2017.
  • Candriam SCA opened 72 new positions and closed 45 in Q4 2017.
  • Candriam SCA's portfolio value rose 0.98% quarter-over-quarter to $5.78B.

Based on Candriam SCA's 13F filing for Q4 2017, filed 7 Feb 2018.